NCT07791420

Brief Summary

Protein consumption is essential for various physiological processes, with microalgae and plant proteins gaining increasing attention due to their health benefits. To better understand how different protein types and processing methods impact health outcomes, this study aims to analyse the metabolite changes in response to different protein sources.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
16mo left

Started Sep 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 28, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2027

4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

August 28, 2026

Status Verified

August 1, 2026

Enrollment Period

12 months

First QC Date

August 19, 2026

Last Update Submit

August 25, 2026

Conditions

Keywords

Protein absorptionAmino acid availabilityMetabolomicsProcessingMicroalgaeAcute

Outcome Measures

Primary Outcomes (2)

  • Changes in metabolites found in plasma (plasma metabolomics)

    Targeted metabolomics profiling of plasma will be conducted using liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS)

    Baseline, 15, 30, 45, 60, 90, 120, 180, 240, 300 minutes

  • Changes in metabolites found in urine (urinary metabolomics)

    Targeted metabolomics profiling of urine will be conducted liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS)

    Baseline and 300 minutes

Secondary Outcomes (1)

  • Appetite

    Baseline, 60, 120, 180, 240, 300 minutes

Study Arms (5)

Bead-milled microalgae

EXPERIMENTAL

Consume a 400 mL drink containing 20 g protein equivalent of bead-milled microalgae

Dietary Supplement: Bead-milled microalgae

Non-bead-milled microalgae

ACTIVE COMPARATOR

Consume a 400 mL drink containing 20 g protein equivalent of non-bead-milled microalgae

Dietary Supplement: Non-bead-milled microalgae

Whey protein isolate

ACTIVE COMPARATOR

Consume a 400 mL drink containing 20 g protein equivalent of whey protein isolate

Dietary Supplement: Whey protein isolate

Soy Protein Isolate

ACTIVE COMPARATOR

Consume a 400 mL drink containing 20 g protein equivalent of soy protein isolate

Dietary Supplement: Soy protein isolate

Maltodextrin

PLACEBO COMPARATOR

Consume a 400 mL drink containing maltodextrin matched for the energy content of 20 g protein

Dietary Supplement: Maltodextrin (Placebo)

Interventions

Bead-milled microalgaeDIETARY_SUPPLEMENT

Consume a 400 mL drink containing 20 g protein equivalent of bead-milled microalgae

Bead-milled microalgae
Non-bead-milled microalgaeDIETARY_SUPPLEMENT

Consume a 400 mL drink containing 20 g protein equivalent of non-bead-milled microalgae

Non-bead-milled microalgae
Whey protein isolateDIETARY_SUPPLEMENT

Consume a 400 mL drink containing 20 g protein equivalent of whey protein isolate

Whey protein isolate
Soy protein isolateDIETARY_SUPPLEMENT

Consume a 400 mL drink containing 20 g protein equivalent of soy protein isolate

Soy Protein Isolate
Maltodextrin (Placebo)DIETARY_SUPPLEMENT

Consume a 400 mL drink containing maltodextrin matched for the energy content of 20 g protein

Maltodextrin

Eligibility Criteria

Age21 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • English-literate and able to give informed consent
  • Singaporean Chinese Adults aged 21 to 60 (inclusive)
  • Body mass index of 18.5 to 23.0 kg/m\^2 (inclusive)
  • Healthy (Based on results from screening session)

You may not qualify if:

  • Currently participating in another clinical study that involves altering the regular diet and/or involves consuming a dietary supplement or investigated food product as an intervention
  • High blood pressure (≥ 140/90 mmHg)
  • Underlying health conditions that may affect metabolic functions
  • Consuming amino acid or protein supplements, or protein drinks, regularly (i.e., more than three times a week) for the past 3 months, and not willing to discontinue usage 3 months before and during the study duration
  • Weight change \> 3 kg in the past 3 months
  • Weight \< 50 kg
  • Exercising vigorously over the past 3 months (i.e., engaging in high-intensity exercises for more than 3 hours a week, where high-intensity exercises leave one out of breath and unable to talk or sing during the workout)
  • Current smokers or have quit smoking for less than 5 years
  • Drinking \> 2 alcoholic drinks per day (i.e., one drink is defined as either 150 ml of wine, 340 ml of beer/cider or 45 ml of distilled spirit)
  • If drinking ≤ 2 alcoholic drinks per day, not willing to stop consumption of alcoholic beverages two days before and on the day of the test visits
  • Not willing to stop consumption of caffeinated beverages 10 to 12 houFrs before and on the day of the test visits
  • Currently on a specialised diet (e.g., Halal, vegetarian, vegan, weight loss diet)
  • Had serious food allergies in the past, or having intolerance, sensitivities or allergies to any of the following: seaweed or algae and their derived products, milk/dairy products (e.g., whey), starch/starch-derived products (e.g., rice, corn, wheat, potato), soy/soy-derived products, gluten, eggs, nuts, peanuts, fish and crustaceans
  • Disease or impairment of the kidney and/or liver\*
  • Currently diagnosed with diabetes\*, gastrointestinal issues (e.g., lactose intolerance, irritable bowel syndrome), gout and/or G6PD deficiency
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NUS, Department of Food Science and Technology, 1 Science Drive 3, Block S13, #03-07, Singapore, 117550

Singapore, Singapore

Location

Related Publications (1)

  • Williamson E, Monteyne AJ, Van der Heijden I, Abdelrahman DR, Murton AJ, Hankamer B, Stephens FB, Wall BT. Ingestion of 'whole cell' or 'split cell' Chlorella sp., Arthrospira sp., and milk protein show divergent postprandial plasma amino acid responses with similar postprandial blood glucose control in humans. Front Nutr. 2024 Nov 14;11:1487778. doi: 10.3389/fnut.2024.1487778. eCollection 2024.

    PMID: 39610880BACKGROUND

MeSH Terms

Interventions

Soybean Proteinsmaltodextrin

Intervention Hierarchy (Ancestors)

Plant ProteinsProteinsAmino Acids, Peptides, and ProteinsPlant Proteins, DietaryDietary ProteinsFoodDiet, Food, and NutritionPhysiological PhenomenaSoy FoodsVegetable ProductsVegetablesFood and Beverages

Study Officials

  • Jung Eun Kim, Ph.D., R.D.

    National University of Singapore, Department of Food Science and Technology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marven Ng, B.Sc.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 19, 2026

First Posted

August 28, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

August 28, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Electronic copies of the data with identifiable participant information will be kept on NUS OneDrive with access limited only to A/P Kim Jung Eun and her research staff. All data will be de-identified prior to statistical analyses.

Locations